Navigation Links
Evotec to Present at the BIO CEO & Investor Conference 2008 in New York
Date:2/8/2008

HAMBURG, Germany and OXFORD, England, February 8 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that Jörn Aldag, President & CEO, will present at the BIO CEO & Investor Conference in New York.

Date: Tuesday, 12 February 2008

Time: 11.45 am EST (05.45 pm CET/04.45 pm GMT)

Location: Waldorf-Astoria, New York City

The presentation slides will be available on the Evotec website at http://www.evotec.com - Investors shortly after the presentation.

Contact:

Evotec AG

Anne Hennecke

SVP, Investor Relations & Corporate Communications

Phone: +49(0)40-56081-286

Fax: +49(0)40-56081-333

E-Mail: anne.hennecke@evotec.com


'/>"/>
SOURCE Evotec AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
2. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
3. Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York
4. Evotec AG: R&D Update on 16 October 2007 Live on the Internet
5. Evotec Reports Third Quarter 2007 Results
6. Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board
7. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
8. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
9. Avicena Group to Present at Noble Financial Conference
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4University of the Basque Country research on plankton at Urdaibai 2Arcadia Resources Announces Webcast of Its Fiscal 2010 First Quarter Conference Call 53598 1Arcadia Resources Announces Webcast of Its Fiscal 2010 First Quarter Conference Call 53598 2VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference 13349 1VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference 13349 2West Announces Second Quarter 2009 Results 53596 1West Announces Second Quarter 2009 Results 53596 2West Announces Second Quarter 2009 Results 53596 3West Announces Second Quarter 2009 Results 53596 4West Announces Second Quarter 2009 Results 53596 5West Announces Second Quarter 2009 Results 53596 6West Announces Second Quarter 2009 Results 53596 7West Announces Second Quarter 2009 Results 53596 8West Announces Second Quarter 2009 Results 53596 9West Announces Second Quarter 2009 Results 53596 10West Announces Second Quarter 2009 Results 53596 11West Announces Second Quarter 2009 Results 53596 12West Announces Second Quarter 2009 Results 53596 13West Announces Second Quarter 2009 Results 53596 14West Announces Second Quarter 2009 Results 53596 15West Announces Second Quarter 2009 Results 53596 16West Announces Second Quarter 2009 Results 53596 17West Announces Second Quarter 2009 Results 53596 18West Announces Second Quarter 2009 Results 53596 19West Announces Second Quarter 2009 Results 53596 20